Air Optix Daily Wear Contact Lenses

Alcon Research312 enrolled

Overview

The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix Aqua, Air Optix plus HydraGlyde Sphere, and Air Optix plus HydraGlyde Toric soft contact lenses in a real-world setting when worn as daily wear.

This is a non-interventional/observational study designed as a retrospective chart review. Study sites will identify charts within their existing databases in a fair and consistent manner, e.g., reviewing all eligible charts in reverse chronological order by year of baseline visit. The baseline visit will be defined as the first office visit where an eye care practitioner provided an in-person office biomicroscopy exam to the patient, before or during which a contact lens prescription for the study or comparator contact lenses was released. Subjects meeting the eligibility criteria will be enrolled in the study.

Study Type

OBSERVATIONAL

Enrollment

312

Conditions

Refractive Errors

Interventions

Lotrafilcon B spherical soft contact lensesDEVICE

Commercially available silicone hydrogel contact lenses

Lotrafilcon B spherical soft contact lenses with comfort additiveDEVICE

Commercially available silicone hydrogel contact lenses

Lotrafilcon B toric soft contact lenses with comfort additiveDEVICE

Commercially available silicone hydrogel contact lenses

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Key Inclusion Criteria: * Manifest refraction cylinder less than or equal to 0.75 diopter (D) in each eye at baseline (sphere wearers only); * Best corrected visual acuity (BCVA) of 20/25 Snellen or better in each eye at baseline; * Must have worn or be wearing Air Optix Aqua Sphere, Air Optix plus HydraGlyde Sphere, Air Optix plus HydraGlyde Toric, Biofinity Sphere or Biofinity Toric for at least 1 year in a daily wear modality, as determined by the Investigator; * Other protocol-defined inclusion criteria may apply. Key Exclusion Criteria: * Have worn or be wearing Air Optix Aqua Sphere, Air Optix plus HydraGlyde Sphere, Air Optix plus HydraGlyde Toric, Biofinity Sphere, or Biofinity Toric contact lenses in an extended wear modality; * Any recurrent history or active anterior segment infection, inflammation or abnormality contraindicating regular contact lens wear at baseline; * Use of systemic or ocular medications contraindicating regular contact lens wear at baseline and/or during the period of the retrospective chart collection; * Slit lamp findings, including signs of pathological dry eye, that would contraindicate regular contact lens wear; * Other protocol-defined exclusion criteria may apply.

Locations (5)

Vision Health Institute

Orlando, Florida, United States

Complete Eye Care of Medina

Medina, Minnesota, United States

Koetting Associates

St Louis, Missouri, United States

Toyos Clinic

Nashville, Tennessee, United States

Outcomes

Primary Outcomes

Distance visual acuity (VA) with study lenses

The subject's chart will be reviewed for distance visual acuity at baseline and at 1 year following the baseline exam.

Time frame: Up to Year 1

Incidence of corneal infiltrative events

The subject's chart will be reviewed for incidences of corneal infiltrative events occurring after the baseline exam.

Time frame: Up to Year 1

Incidence of microbial keratitis

The subject's chart will be reviewed for incidences of microbial keratitis occurring after the baseline exam.

Time frame: Up to Year 1

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.